10.04.2006 16:29:00

Macrovision's FLEXnet Publisher Solution Selected by Thermo

Macrovision(R) Corporation (Nasdaq:MVSN) today announcedthat Thermo Electron Corporation will use Macrovision's electroniclicensing software to automate licensing models for Thermo'sinformatics solutions, providing its customers with flexible optionsfor pricing, packaging and product usage.

Global hardware and software organizations across all industries-- such as life sciences, manufacturing, electronics, healthcare andautomotive -- are migrating towards a more software-centric businessmodel to add value to and differentiate their products. By automatingtheir licensing models, companies can benefit from electroniclicensing, entitlement management and electronic updates. They canmanage their business more effectively and respond faster to marketchange and customer requests.

Thermo will implement Macrovision's FLEXnet Publisher across allof its informatics products.

"Providing electronic licensing models is an important benefit tocustomers, as many have unique procurement requirements that areeasily enabled by electronic licensing," said David Shin, director oftechnology of Thermo's Informatics business. "The integration ofMacrovision's digital value management offerings with our products andacross our supply chain will help us serve a broader target audience,improving operational efficiencies and enabling high levels ofcustomer self service."

FLEXnet Publisher allows users access to product components thatare most applicable and beneficial to their responsibilities. Andbased on metrics that are defined in the licensing agreement andenforced electronically by FLEXnet Publisher, customers will be ableto track how much and how often a product is used by individuals orgroups. Additionally, customers will be able to quickly log into anapplication, whether just once or multiple times daily, and do it justas seamlessly whether they are across the hall from their central labor across the globe.

By having the flexibility to easily access applications from anylocation, Thermo's customers can monitor their internal usage ofThermo's products, track their own entitlements more effectively andcapture audit trails of product usage -- all of which will help thembetter comply with FDA mandates.

"We are very pleased to welcome Thermo to our family ofMacrovision customers," said Fred Amoroso, CEO of Macrovision. "We arecommitted to helping Thermo successfully automate its informaticslicensing models so they can continue to bring value to theircustomers."

Three of the world's largest life sciences companies and three ofthe largest global medical equipment suppliers use Macrovision'sFLEXnet Publisher software. This underscores the strategic importanceof electronic licensing in the life sciences and medical equipmentverticals, where FDA compliance strongly impacts technology, usagemodels, auditing and business models.

About Macrovision Corporation

Macrovision provides distribution, commerce and consumptionsolutions for software and entertainment content to the home video, PCgames, music, cable/satellite, consumer software, and enterprisesoftware industries. Macrovision holds a total of 220 issued orpending United States patents and 1,200 issued or pendinginternational patents, and continues to increase its patent portfoliowith new and innovative technologies in related fields. Macrovision isheadquartered in Santa Clara, California, U.S.A. with other officesacross the United States and around the world. More information aboutMacrovision can be found at www.macrovision.com.

(C)Macrovision 2006. Macrovision and FLEXnet are registeredtrademarks or trademarks of Macrovision Corporation. All other brandsand product names and trademarks are the registered property of theirrespective companies.

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu Rovi Corpmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Rovi Corpmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 19 926,72 0,12%